{"id":"W2043470852","doi":"10.1371/journal.pone.0065569","title":"Novel Combination of Sorafenib and Celecoxib Provides Synergistic Anti-Proliferative and Pro-Apoptotic Effects in Human Liver Cancer Cells","year":2013,"lang":"en","type":"article","venue":"PLoS ONE","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hôtel-Dieu de Québec; Université Laval; Centre hospitalier universitaire de Québec","funders":"Centre Hospitalier Universitaire de Québec; Ministero dell’Istruzione, dell’Università e della Ricerca","keywords":"Sorafenib; Cancer research; Cell cycle; Cell growth; Apoptosis; Celecoxib; Cancer cell; Liver cancer; Cell culture; Signal transduction; Biology; Transcriptome; Programmed cell death; Cancer; Pharmacology; Gene expression; Hepatocellular carcinoma; Gene; Cell biology; Biochemistry; Genetics","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001467923,0.0001531467,0.0004505436,0.0001412708,0.00004896144,0.00001726612,0.00003283807,0.00008978822,0.00002826335],"category_scores_gemma":[0.0001361255,0.0001298976,0.00001816486,0.0001076018,0.0001048627,0.0001305999,0.00003075238,0.000157849,0.000005549376],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004776636,"about_ca_system_score_gemma":0.00004993065,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003572982,"about_ca_topic_score_gemma":0.00004951465,"domain_scores_codex":[0.9990684,0.0000554652,0.0002329346,0.0002245597,0.0002191557,0.0001994796],"domain_scores_gemma":[0.9993669,0.0001561708,0.0001130692,0.0001159684,0.0001427826,0.0001050477],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00003510221,0.001123755,0.0367086,0.003786301,0.00009960742,0.00001198027,0.0008055394,0.000001863579,0.9568362,0.0002525308,0.00002902656,0.0003094386],"study_design_scores_gemma":[0.002703152,0.0005900734,0.2422559,0.001292688,0.0002127276,0.000001672501,0.00002247484,0.005353745,0.7473494,0.00008460229,6.830678e-7,0.0001328927],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9971576,0.00049946,0.00002620108,0.00008788652,0.00003259278,0.002095602,0.000004344043,0.00002159362,0.00007470129],"genre_scores_gemma":[0.9989769,0.00008466126,0.0004000176,0.00006537556,0.00006263185,0.0002573711,0.000007530654,0.00002152173,0.000123993],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2094869,"threshold_uncertainty_score":0.529707,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02274846759049533,"score_gpt":0.2369083339074096,"score_spread":0.2141598663169142,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}